PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs

The tyrosine kinase inhibitors (TKIs) targeting epidermal growth factor receptor (EGFR) have been widely used for non-small cell lung cancer (NSCLC) patients, but the development of acquired resistance remains a therapeutic hurdle. The reduction of glucose uptake has been implicated in the anti-tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chia-Hung, Wang, Bo-Wei, Hsiao, Yu-Chun, Wu, Chun-Yi, Cheng, Fang-Ju, Hsia, Te-Chun, Chen, Chih-Yi, Wang, Yihua, Weihua, Zhang, Chou, Ruey-Hwang, Tang, Chih-Hsin, Chen, Yun-Ju, Wei, Ya-Ling, Hsu, Jennifer L., Tu, Chih-Yen, Hung, Mien-Chie, Huang, Wei-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298203/
https://www.ncbi.nlm.nih.gov/pubmed/34155348
http://dx.doi.org/10.1038/s41388-021-01889-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298203/
https://www.ncbi.nlm.nih.gov/pubmed/34155348
http://dx.doi.org/10.1038/s41388-021-01889-0

Ejemplares similares